ArticlebioRxiv : the preprint server for biology2025
Integrating single-cell and single-nucleus datasets improves bulk RNA-seq deconvolution.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
2 authors.
Funding
Abstract
Bulk RNA-seq deconvolution typically uses single-cell RNA-sequencing (scRNA-seq) references, but some cell types are only detectable through single-nucleus RNA sequencing (snRNA-seq). Because snRNA-seq captures nuclear, but not cytoplasmic, transcripts, direct use as a reference could reduce deconvolution accuracy. Here, we systematically benchmark strategies to integrate both modalities, focusing on transformations and gene-filtering approaches that harmonize snRNA-seq with scRNA-seq references. Across four diverse tissues, we evaluated principal component-based shifts, conditional and non-conditional variational autoencoders (scVI), and the removal of cross-modality differentially expressed genes (DEGs). While all methods improved performance relative to untransformed snRNA-seq, filtering consistent cross-modality DEGs delivered the greatest gains, often matching or surpassing scRNA-only references. Conditional scVI performed comparably and was especially effective when matched scRNA-snRNA cell types were unavailable. In real adipose bulk samples without ground truth, DEG pruning and conditional scVI provided the most robust cell-fraction estimates across donors and transformations. Together, these results demonstrate that scRNA-seq should be prioritized as the reference when available, with snRNA-seq appended only after filtering cross-modality DEGs. For less-characterized systems where DEG information is limited, conditional scVI offers a practical alternative. Our findings provide clear guidelines for modality-aware integration, enabling near-scRNA-seq accuracy in bulk deconvolution workflows.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.